lobbying_activities: 3381875

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3381875	e70a61ce-976f-4300-aae6-23428fb44d3d	Q2	AMERICAN VETERINARY MEDICAL ASSOCIATION	3630	AMERICAN VETERINARY MEDICAL ASSOCIATION	2025	second_quarter	PHA	Xylazine; Combating Illicit Xylazine Act (HR1266/S545); Controlled Substances used in veterinary medicine, Controlled Substances Act and regulations as related to veterinary medicine. Issues related to the FDA CVM.	HOUSE OF REPRESENTATIVES,SENATE		100000	0	0	2025-07-14T15:47:58-04:00